Back to news

Case Law Digest Series

April 6, 2026

Employee Share Options: High Court Quantifies Equitable Compensation for Former Employee Denied Right to Exercise

English High Court determines valuation of share options for ex-employee under proprietary estoppel, applying bulk sale price in Dixon v GlobalData PLC.

The High Court has determined the relief due to a former employee following its earlier decision in <span class="news-text_italic-underline">Dixon v GlobalData PLC [2025] EWHC 2156 (Ch)</span>, in which the Court held that the claimant was entitled to a remedy grounded in proprietary estoppel.

Background

In the 2025 judgment, the Court found that the defendant had assured the claimant that, notwithstanding the ending of his employment, his share options would remain exercisable. In reliance on that assurance, the claimant extended his employment by three months and accepted restrictive covenants. When he subsequently sought to exercise his options, the defendant contended that they had lapsed upon termination of employment. The Court upheld the claimant's proprietary estoppel claim and found him entitled to a remedy.

Issues Before the Court

The proceedings addressed two questions: first, how equitable compensation in respect of the "tranche 2" options should be valued; and secondly, whether the "tranche 3" options fell within the scope of the relief to which the claimant was entitled.

Valuation of Tranche 2 Options

The claimant contended for a higher valuation based on the market price of the defendant's shares on the date the company communicated its refusal to permit him to exercise his options. The Court rejected this approach. Applying the principles set out in <span class="news-text_italic-underline">Guest v Guest [2022] UKSC 27</span>, it held that the claimant should be compensated by reference to the lower price actually applied to other option holders who had elected to exercise and sell their options through a bulk sale process. This approach more accurately reflected the expectation created by the company's assurance — namely, that the claimant was to be treated in the same manner as other plan participants and avoided placing him in a more favourable position than those participants.

Tranche 3 Options

The Court further held that the tranche 3 options also fell within the ambit of the claimant's entitlement to relief. These were replacement options granted in 2021 following the expiry of the original ten-year plan and had not been extended to the claimant on account of his having left employment. However, given that all other continuing plan members had received replacement options, the Court found it unconscionable to exclude the claimant from that benefit. He was accordingly awarded equitable compensation in respect of both tranches 2 and 3, calculated by reference to the market price used to determine sale proceeds for other option holders in the bulk sale process.

<span class="news-text_medium">Case:</span> <span class="news-text_italic-underline">Dixon v GlobalData PLC [2026] EWHC 850 (Ch)</span> (15 April 2026, Master Brightwell)

Address
London:
2 Eaton Gate
London SW1W 9BJ
New York:
295 Madison Avenue 12th Floor
New York City, NY 10017
Paris:
56 Avenue Kléber
75116 Paris
Singapore:
Level 11, Marina Bay Financial Centre
Tower 1, 8 Marina Boulevard,
Singapore 018981
Belgravia Law is a London-based dispute resolution boutique recognized in The Legal 500 for mid-market commercial litigation.Belgravia Law ranked by 'Chamber and Partners' as Leading firm in UK 2026 (band 4)
Belgravia Law is a London-based dispute resolution boutique recognized in The Legal 500 for mid-market commercial litigation.Belgravia Law ranked by 'Chamber and Partners' as Leading firm in UK 2026 (band 4)
BELGRAVIA LAW LIMITED is registered with the Solicitors Regulation Authority with SRA number 8004056 and is a limited company registered in England & Wales with company number 14815978. The firm’s registered office is at 2 Eaton Gate, Belgravia, London SW1W 9BJ.

‘Belgravia Law’ (c) 2026. All rights reserved.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our Privacy Policy and Cookie Policy for more information.